Orange, Calif.; and Durham, N.C. From the Aesthetic and Plastic Surgery Institute, University of California, Irvine, and the Department of Statistical Sciences, Duke University. The first two authors should be considered co-first authors.
Plast Reconstr Surg. 2013 Aug;132(2):443-450. doi: 10.1097/PRS.0b013e3182958945.
The purpose of this study was to determine the evidenced-based value of prophylactic drainage of subcutaneous wounds in surgery.
An electronic search was performed. Articles comparing subcutaneous prophylactic drainage with no drainage were identified and classified by level of evidence. If sufficient randomized controlled trials were included, a meta-analysis was performed using the random-effects model. Fifty-two randomized controlled trials were included in the meta-analysis, and subgroups were determined by specific surgical procedures or characteristics (cesarean delivery, abdominal wound, breast reduction, breast biopsy, femoral wound, axillary lymph node dissection, hip and knee arthroplasty, obesity, and clean-contaminated wound). Studies were compared for the following endpoints: hematoma, wound healing issues, seroma, abscess, and infection.
Fifty-two studies with a total of 6930 operations were identified as suitable for this analysis. There were 3495 operations in the drain group and 3435 in the no-drain group. Prophylactic subcutaneous drainage offered a statistically significant advantage only for (1) prevention of hematomas in breast biopsy procedures and (2) prevention of seromas in axillary node dissections. In all other procedures studied, drainage did not offer an advantage.
Many surgical operations can be performed safely without prophylactic drainage. Surgeons can consider omitting drains after cesarean section, breast reduction, abdominal wounds, femoral wounds, and hip and knee joint replacement. Furthermore, surgeons should consider not placing drains prophylactically in obese patients. However, drain placement following a surgical procedure is the surgeon's choice and can be based on multiple factors beyond the type of procedure being performed or the patient's body habitus.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.
本研究旨在确定手术中预防性皮下引流的循证价值。
进行电子检索。确定并按证据水平对比较皮下预防性引流与不引流的文章进行分类。如果纳入足够的随机对照试验,则使用随机效应模型进行荟萃分析。共有 52 项随机对照试验纳入荟萃分析,并根据特定手术程序或特征(剖宫产、腹部伤口、乳房缩小术、乳房活检、股部伤口、腋窝淋巴结清扫术、髋关节和膝关节置换术、肥胖和污染伤口)确定亚组。比较研究的以下结局:血肿、伤口愈合问题、血清肿、脓肿和感染。
确定了 52 项共 6930 例手术的研究适合进行此分析。引流组有 3495 例手术,非引流组有 3435 例。预防性皮下引流仅在(1)乳房活检术预防血肿和(2)腋窝淋巴结清扫术预防血清肿方面具有统计学优势。在所有其他研究的手术程序中,引流均无优势。
许多手术操作可以安全地进行,无需预防性引流。对于剖宫产、乳房缩小术、腹部伤口、股部伤口和髋关节及膝关节置换术,外科医生可以考虑不放置引流管。此外,对于肥胖患者,外科医生应考虑不预防性放置引流管。然而,引流管的放置是外科医生的选择,可以基于手术类型或患者体型以外的多种因素。
临床问题/证据水平:治疗性,II 级。